Return to Previous Page

Treatment Guidelines for Stage IV Non-Small Cell Lung Cancer Updated


New recommendations on the use of chemotherapy to treat people with Stage IV non-small cell lung cancer have been issued by the American Society of Clinical Oncology. The evidence-based clinical practice guideline indicates a person’s physical age should not determine the cancer treatment he or she is given. Instead, ASCO recommends oncologists take other factors into account, including physiological age and performance status, when determining appropriate treatment for people with Stage IV NSCLC.

The updated guideline, decision aid tools, and other resources are available at ASCO.org/guidelines/nsclc. ASCO also has developed a corresponding patient guide available at Cancer.Net.

 

 

 

 

 

 

♦ ♦ ♦ ♦ ♦

This article was published in Coping® with Cancer magazine, January/February 2010.

 

Related Articles

 

Facing Lung Cancer
 

Lung Cancer 101
 

Commit to Quit
 

 

{snp_right_no_ad}